Voloridge Investment Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
34,966
+2,600
| +8% | +$95.7K | ﹤0.01% | 998 |
|
|
2025
Q1 | $1.14M | Sell |
32,366
-15,485
| -32% | -$548K | ﹤0.01% | 1031 |
|
|
2024
Q4 | $2.09M | Buy |
47,851
+21,337
| +80% | +$933K | 0.01% | 935 |
|
|
2024
Q3 | $1.2M | Sell |
26,514
-13,771
| -34% | -$625K | ﹤0.01% | 1005 |
|
|
2024
Q2 | $1.56M | Sell |
40,285
-30,548
| -43% | -$1.19M | 0.01% | 987 |
|
|
2024
Q1 | $2.28M | Buy |
+70,833
| New | +$2.28M | 0.01% | 828 |
|
|
2023
Q2 | – | Sell |
-27,033
| Closed | -$586K | – | 1535 |
|
|
2023
Q1 | $586K | Sell |
27,033
-69,077
| -72% | -$1.5M | ﹤0.01% | 1199 |
|
|
2022
Q4 | $2.29M | Sell |
96,110
-154,461
| -62% | -$3.68M | 0.01% | 927 |
|
|
2022
Q3 | $4.94M | Buy |
250,571
+138,437
| +123% | +$2.73M | 0.03% | 656 |
|
|
2022
Q2 | $2.19M | Buy |
112,134
+19,309
| +21% | +$376K | 0.01% | 988 |
|
|
2022
Q1 | $2.37M | Buy |
+92,825
| New | +$2.37M | 0.01% | 888 |
|
|
2021
Q4 | – | Sell |
-53,384
| Closed | -$1.47M | – | 1813 |
|
|
2021
Q3 | $1.47M | Buy |
53,384
+39,683
| +290% | +$1.09M | 0.01% | 1157 |
|
|
2021
Q2 | $435K | Sell |
13,701
-36,440
| -73% | -$1.16M | ﹤0.01% | 1463 |
|
|
2021
Q1 | $2.3M | Sell |
50,141
-37,194
| -43% | -$1.71M | 0.02% | 774 |
|
|
2020
Q4 | $3.46M | Buy |
+87,335
| New | +$3.46M | 0.03% | 558 |
|